Overview
Xianling Liu practices in Changsha, China. Liu is highly rated in 5 conditions, according to our data. Their top areas of expertise are Nasopharyngeal Carcinoma, Lung Cancer, Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), and Tissue Biopsy.
Their clinical research consists of co-authoring 79 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung AdenocarcinomaLiu isAdvanced. Learn about Lung Adenocarcinoma.
- Lung CancerLiu isAdvanced. Learn about Lung Cancer.
- Nasopharyngeal Carcinoma
- Non-Small Cell Lung Cancer (NSCLC)
- Tissue BiopsyLiu isAdvanced. Learn about Tissue Biopsy.
- Experienced
- B-Cell LymphomaLiu isExperienced. Learn about B-Cell Lymphoma.
- Cervical CancerLiu isExperienced. Learn about Cervical Cancer.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- EGFR Positive Lung CancerLiu isExperienced. Learn about EGFR Positive Lung Cancer.
- FibrosarcomaLiu isExperienced. Learn about Fibrosarcoma.
- Head and Neck Squamous Cell Carcinoma (HNSCC)